newsfilter
← Latest News
Business Wire·

Athersys Expands IP Protection with First New Patent for SIFU® Technology

Novel Ultracold Storage System Ready for Commercial Licensing Athersys, Inc. (NASDAQ:ATHX), a cell therapy and regenerative medicine company developing MultiStem® (invimestrocel) for critical care indications,